PA452
产品说明书
 |
同义名 : | - |
| CAS号 : | 457657-34-0 | |
| 货号 : | A874797 | |
| 分子式 : | C26H37N3O3 | |
| 纯度 : | 99% | |
| 分子量 : | 439.59 | |
| MDL号 : | MFCD28133393 | |
| 存储条件： |
Pure form Sealed in dry, 2-8°C In solvent -20°C:3-6个月-80°C:12个月 |
|
| 溶解度 : | - | |
| 动物实验配方： |
| 临床研究 | |||||
|---|---|---|---|---|---|
| NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
| NCT02047734 | Relapsing Multiple Sclerosis | Phase 2 Phase 3 | Completed | - | - |
| NCT03347110 | Psoriatic Arthritis | Phase 2 | Active, not recruiting | November 2020 | - |
| NCT02969525 | Psoriatic Arthritis | Phase 2 | Completed | - | - |
| 实验方案 | |||
|---|---|---|---|
| 1mg | 5mg | 10mg | |
|
1 mM 5 mM 10 mM |
2.27mL 0.45mL 0.23mL |
11.37mL 2.27mL 1.14mL |
22.75mL 4.55mL 2.27mL |
